Clinical Trial Update: A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 safety study of MM-121 in combination with cetuximab and irinotecan in patients with advanced cancers, including colorectal cancer and head and neck squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• MM-121 (seribantumab)

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Colorectal Cancer, Squamous Cell Head and Neck Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-09-08